Literature DB >> 132684

Cholinergic imbalance hypotheses of psychoses and movement disorders: strategies for evaluation.

K L Davis, L E Hollister, P A Berger, J D Barchas.   

Abstract

It has been proposed that the etiologies of tardive dyskinesia and Huntington's chorea and of some forms of schizophrenia and the affective disorders involve a cholinergic imbalance with respect to a second neurotransmitter. This relative over- or underactivity of the cholinergic system could result from altered synthesis, storage, release, degradation, or reuptake or from a variety of receptor interactions. Under these hypotheses, clinical symptoms would reflect both the brain region in which the imbalance occurs and the neurotransmitter with which acetylcholine is interacting. Effective treatments could involve the correction of this hypothetical imbalance by changing the relative availability of either one or both of the neurotransmitters. Both precursor loading with choline or dimethylaminoethanol and cholinesterase inhibition may be useful in evaluating the effects of increased cholinergic activity in these disease states; the relative merits of these strategies are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 132684

Source DB:  PubMed          Journal:  Psychopharmacol Commun        ISSN: 0098-616X


  7 in total

1.  Reversal of scopolamine-induced disruption of prepulse inhibition by clozapine in mice.

Authors:  Philipp Singer; Benjamin K Yee
Journal:  Pharmacol Biochem Behav       Date:  2011-12-21       Impact factor: 3.533

Review 2.  Cholinergic contributions to the cognitive symptoms of schizophrenia and the viability of cholinergic treatments.

Authors:  Martin Sarter; Cindy Lustig; Stephan F Taylor
Journal:  Neuropharmacology       Date:  2010-12-13       Impact factor: 5.250

3.  Ineffectiveness of deanol in tardive dyskinesia: a placebo controlled study.

Authors:  C de Montigny; G Chouinard; L Annable
Journal:  Psychopharmacology (Berl)       Date:  1979-11       Impact factor: 4.530

4.  Mood alterations during deanol therapy.

Authors:  D E Casey
Journal:  Psychopharmacology (Berl)       Date:  1979-04-11       Impact factor: 4.530

5.  Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders.

Authors:  K L Davis; L E Hollister; J Livesey; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1979-05-25       Impact factor: 4.530

6.  Alterations in cerebrospinal fluid dopamine metabolites following physostigmine infusion.

Authors:  K L Davis; K F Faull; L E Hollister; J D Barchas; P A Berger
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

Review 7.  Central neurotransmitter function and its behavioral correlates in man.

Authors:  I Hanin
Journal:  Environ Health Perspect       Date:  1978-10       Impact factor: 9.031

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.